Antidepressants may not improve likelihood of completing HCV treatment

11/22/2013 | Healio (free registration)

Authors of a review found giving hepatitis C patients prophylactic antidepressants did not increase compliance with interferon-based treatment regimens. University of Texas researchers said depression may affect as many as 30% of HCV patients, but while antidepressants were associated with reduced symptoms, they did not lead to better treatment completion rates.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX